3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
19
Lung Neoplasms
14
Multiple Myeloma
13
Leukemia, Myeloid, Acute
13
Glioma
10
Wilms Tumor
9
Lymphoma, Non-Hodgkin
9
Breast Neoplasms
9
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Myelodysplastic Syndromes
8
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Rhabdoid Tumor
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Leukemia, Biphenotypic, Acute
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Sarcoma, Ewing
5
Rectal Neoplasms
5
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Platinum
6
Cyclophosphamide
6
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
atezolizumab
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
X-Rays
×
1 year
×
Clear all
No trials found.